Suppr超能文献

在 HIV 诊所中实施异烟肼预防治疗:来自里约 TB/HIV(THRio)研究的经验。

The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.

机构信息

Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

AIDS. 2010 Nov;24 Suppl 5(Suppl 5):S49-56. doi: 10.1097/01.aids.0000391022.95412.a6.

Abstract

OBJECTIVE

The TB/HIV in Rio (THRio) study was launched in September 2005 to assess the impact of integrated tuberculosis (TB) and HIV treatment strategies in 29 HIV clinics in Rio de Janeiro, Brazil.

DESIGN

THRio is a cluster-randomized trial (CRT) to determine whether routine screening for and treatment of latent TB in HIV clinic patients with access to antiretroviral therapy will reduce TB incidence at the clinic level. THRio is part of the Consortium to Respond Effectively to AIDS/TB Epidemic that is implementing research studies to assess the impact of bold, new public health paradigms for controlling the AIDS/TB epidemic.

METHODS

Twenty-nine public primary HIV clinics were randomly assigned a date to begin implementing TB screening procedures and provision of isoniazid preventive therapy (IPT) for TB/HIV coinfected patients. Final analysis of the CRT is expected in 2011.

RESULTS

Starting at date of tuberculin skin test (TST)/IPT implementation at each clinic through August 2010, 1670 HIV-infected patients initiated IPT, of which 215 are still receiving treatment. Of the remaining 1455 patients, 1230 (85%) completed therapy and only 20 (1.2%) patients initiating IPT reported adverse reactions leading to discontinuation of therapy. IPT completion was higher among HIV-infected patients receiving HAART (87%) than those not yet receiving HAART (79%, P < 0.01). Times to TST and IPT have markedly decreased postintervention, but remain considerably long. The richness of the THRio database has resulted in several analyses of this expansive cohort of HIV-infected patients that are reviewed here.

CONCLUSIONS

The national implementation of TST and IPT for HIV-positive patients in Brazil has been invigorated partly due to THRio's baseline results. Expanded use of IPT in HIV patients in Rio de Janeiro is achievable with high adherence and low adverse events, although this effort requires a package of activities including training, advocacy and reorganization of services.

摘要

目的

TB/HIV 在里约(THRio)研究于 2005 年 9 月启动,旨在评估在巴西里约热内卢的 29 个艾滋病毒诊所实施综合结核病(TB)和艾滋病毒治疗策略的影响。

设计

THRio 是一项集群随机试验(CRT),旨在确定在获得抗逆转录病毒治疗的艾滋病毒诊所患者中,常规筛查和治疗潜伏性结核病是否会降低诊所层面的结核病发病率。THRio 是应对艾滋病/结核病流行的有效联盟的一部分,该联盟正在实施研究,以评估控制艾滋病/结核病流行的大胆新公共卫生模式的影响。

方法

29 家公立初级艾滋病毒诊所被随机分配一个日期,开始实施结核病筛查程序,并为结核病/艾滋病毒合并感染患者提供异烟肼预防性治疗(IPT)。预计 CRT 的最终分析将于 2011 年进行。

结果

截至 2010 年 8 月,每个诊所开始进行结核菌素皮肤试验(TST)/IPT 的日期,已有 1670 名艾滋病毒感染者开始接受 IPT,其中 215 人仍在接受治疗。在其余的 1455 名患者中,有 1230 名(85%)完成了治疗,只有 20 名(1.2%)开始接受 IPT 的患者报告不良反应导致治疗中断。正在接受高效抗逆转录病毒治疗(HAART)的艾滋病毒感染者中,IPT 完成率(87%)高于未接受 HAART 的患者(79%,P < 0.01)。TST 和 IPT 的时间在干预后明显缩短,但仍相当长。THRio 数据库的丰富性导致对这一广泛的艾滋病毒感染者队列进行了几次分析,这里对此进行了综述。

结论

巴西全国范围内为艾滋病毒阳性患者实施 TST 和 IPT 的工作因 THRio 的基线结果而得到了加强。里约热内卢的艾滋病毒患者中扩大使用 IPT 是可行的,且具有较高的依从性和较低的不良事件发生率,尽管这需要一整套活动,包括培训、宣传和服务重组。

相似文献

引用本文的文献

本文引用的文献

1
Treatment of latent tuberculosis infection in HIV infected persons.HIV感染者潜伏性结核感染的治疗。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000171. doi: 10.1002/14651858.CD000171.pub3.
2

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验